Sutro Biopharma Inc (STRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Sales | 11,305 | 12,277 | 10,525 | 8,629 | 19,086 |
| Gross Profit | 11,305 | 12,277 | 10,525 | 8,629 | 19,086 |
| Operating Expenses | 26,087 | 25,012 | 24,210 | 22,895 | 22,361 |
| Operating Income | -14,782 | -12,735 | -13,685 | -14,266 | -3,275 |
| Interest Expense | 817 | 1,141 | 1,232 | 1,160 | -649 |
| Other Income | 810 | 964 | 1,124 | 1,176 | 1,133 |
| Pre-tax Income | -14,789 | -12,912 | -13,793 | -14,250 | -1,493 |
| Net Income Continuous | -14,789 | -12,912 | -13,793 | -14,250 | -1,493 |
| Net Income | $-14,789 | $-12,912 | $-13,793 | $-14,250 | $-1,493 |
| EPS Basic Total Ops | -6.50 | -5.60 | -6.00 | -6.20 | 650.50 |
| EPS Basic Continuous Ops | -6.40 | -5.63 | -6.02 | -6.23 | 649.90 |
| EPS Diluted Total Ops | -6.50 | -5.60 | -6.00 | -6.20 | 650.50 |
| EPS Diluted Continuous Ops | -6.40 | -5.63 | -6.02 | -6.23 | 649.90 |
| EBITDA(a) | $-13,694 | $-11,569 | $-13,156 | $-13,729 | $-2,501 |